Enhancing ablation effects of a microbubble contrast agent on high‐intensity focused ultrasound: an experimental and clinical study
Authors:
- 30 August 2017
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 124 (S3) , 78-86
Abstract
Objective: To investigate the relationship between SonoVue ablation enhancement effects on high‐intensity focused ultrasound (HIFU) and the concentration of SonoVue and timing of HIFU.Design: Two randomised controlled trials.Setting: An animal centre in a university and a gynaecological department in a university hospital in China.Population or sample: 63 rabbits and 143 patients with a solitary uterine fibroid.Methods: Among the 63 rabbits, three were assigned to the control group. The other 60 were evenly assigned to three study groups pretreated with 0.03, 0.05 or 0.07 ml/kg of SonoVue before HIFU treatment. Two points in each liver were selected to be treated with HIFU and sonication started at 10, 30, 60, 90, 120, 150, 180, 210, 250 or 300 seconds after the administration of SonoVue, respectively. The 143 patients with solitary uterine fibroids were assigned to four groups: 30 patients were treated using only HIFU; the other patients were pretreated with same dosage of SonoVue and 32, 38 and 43 were treated with HIFU at 1‐, 3‐, and 5‐minutes after administration of SonoVue, respectively.Main outcome measures: The relation between SonoVue ablation enhancement effects on HIFU and the concentration of SonoVue and timing of HIFU.Results: In the experimental study, the highest temperature and the largest necrotic volume in the liver were observed when HIFU sonication started at 60 seconds after administration of SonoVue. In the clinical study, the rate of significant grey‐scale changes in the 1‐minute SonoVue group was significantly greater than in the other three groups. The sonication time to reach massive grey‐scale changes measured in the 1‐minute SonoVue group was significantly shorter than in in the other three groups. The sonication time for ablating 1 cm3 of fibroid volume in the 1‐minute SonoVue group was significantly shorter than in the other three groups. The acoustic energy used in treating 1 mm3 of uterine fibroid in the 1‐minute SonoVue group was significantly less than that used in the other three groups. No major complications occurred in this study.Conclusions: SonoVue could safely be used to enhance the ablation effects of HIFU treatment, and the optimal time to begin HIFU sonication seems to be 1 minute after the administration of SonoVue.Tweetable SonoVue, a microbubble contrast agent, enhanced the ablation effects of HIFU treatment; the optimal time to begin HIFU sonication appears to be 1 minute after the administration of SonoVue.Keywords
This publication has 20 references indexed in Scilit:
- Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasoundAbdominal Radiology, 2013
- Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over timeEuropean Radiology, 2012
- Utility of contrast‐enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2011
- Image-guided Tumor Ablation: Standardization of Terminology and Reporting CriteriaJournal of Vascular and Interventional Radiology, 2009
- Ablation of High-Intensity Focused Ultrasound Assisted with SonoVue on Rabbit VX2 Liver Tumors: Sequential Findings with Histopathology, Immunohistochemistry, and Enzyme HistochemistryAnnals of Surgical Oncology, 2009
- Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agentJournal of Cardiovascular Medicine, 2009
- Bio-effects of ultrasound contrast agents in daily clinical practice: fact or fiction?European Heart Journal, 2007
- The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigationsUltrasound in Medicine & Biology, 2006
- The use of a microbubble agent to enhance rabbit liver destruction using high intensity focused ultrasoundUltrasonics Sonochemistry, 2006
- Erythrocytes, as well as microbubble contrast agents, are important factors in improving thermal and therapeutic effects of high-intensity focused ultrasoundUltrasound in Medicine & Biology, 2005